197 related articles for article (PubMed ID: 24291668)
1. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK).
Li W; Chen W; Herberman RB; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Lett; 2014 Mar; 344(2):212-22. PubMed ID: 24291668
[TBL] [Abstract][Full Text] [Related]
2. Rules to activate CD8
Jiao X; Wang X; Wang R; Geng J; Liu N; Chen H; Griffin N; Shan F
Int Immunopharmacol; 2018 Dec; 65():76-83. PubMed ID: 30290369
[TBL] [Abstract][Full Text] [Related]
3. Methionine enkephalin (MENK) mounts antitumor effect via regulating dendritic cells (DCs).
Meng Y; Gao X; Chen W; Plotnikoff NP; Griffin N; Zhang G; Shan F
Int Immunopharmacol; 2017 Mar; 44():61-71. PubMed ID: 28088065
[TBL] [Abstract][Full Text] [Related]
4. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
[TBL] [Abstract][Full Text] [Related]
5. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
[TBL] [Abstract][Full Text] [Related]
6. T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
Zagon IS; Donahue RN; Bonneau RH; McLaughlin PJ
Immunobiology; 2011 May; 216(5):579-90. PubMed ID: 20965606
[TBL] [Abstract][Full Text] [Related]
7. NFAT-1 hyper-activation by methionine enkephalin (MENK) significantly induces cell apoptosis of rats C6 glioma in vivo and in vitro.
Lu WC; Xie H; Tie XX; Wang R; Wu AH; Shan FP
Int Immunopharmacol; 2018 Mar; 56():1-8. PubMed ID: 29324390
[TBL] [Abstract][Full Text] [Related]
8. Functional modulation of the pathway between dendritic cells (DCs) and CD4+T cells by the neuropeptide: methionine enkephalin (MENK).
Shan F; Xia Y; Wang N; Meng J; Lu C; Meng Y; Plotnikoff NP
Peptides; 2011 May; 32(5):929-37. PubMed ID: 21335041
[TBL] [Abstract][Full Text] [Related]
9. Killing effect of methionine enkephalin on melanoma in vivo and in vitro.
Wang DM; Jiao X; Plotnikoff NP; Griffin N; Qi RQ; Gao XH; Shan FP
Oncol Rep; 2017 Oct; 38(4):2132-2140. PubMed ID: 28849104
[TBL] [Abstract][Full Text] [Related]
10. Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK).
Liu J; Chen W; Meng J; Lu C; Wang E; Shan F
Cancer Immunol Immunother; 2012 Oct; 61(10):1699-711. PubMed ID: 22392190
[TBL] [Abstract][Full Text] [Related]
11. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
Huang H; Li F; Gordon JR; Xiang J
Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
13. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
14. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
Williams NS; Engelhard VH
J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
[TBL] [Abstract][Full Text] [Related]
15. B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases.
Zagon IS; Donahue RN; Bonneau RH; McLaughlin PJ
Immunobiology; 2011; 216(1-2):173-83. PubMed ID: 20598772
[TBL] [Abstract][Full Text] [Related]
16. Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment.
Wang X; Li S; Yan S; Shan Y; Wang X; Jingbo Z; Wang Y; Shan F; Griffin N; Sun X
Int Immunopharmacol; 2022 Oct; 111():109125. PubMed ID: 35988519
[TBL] [Abstract][Full Text] [Related]
17. Methionine-enkephalin secreted by human colorectal cancer cells suppresses T lymphocytes.
Ohmori H; Fujii K; Sasahira T; Luo Y; Isobe M; Tatsumoto N; Kuniyasu H
Cancer Sci; 2009 Mar; 100(3):497-502. PubMed ID: 19141128
[TBL] [Abstract][Full Text] [Related]
18. Methionine-enkephalin stimulates hydrogen peroxide and nitric oxide production in rat peritoneal macrophages: interaction of mu, delta and kappa opioid receptors.
Vujić V; Stanojević S; Dimitrijević M
Neuroimmunomodulation; 2004; 11(6):392-403. PubMed ID: 15467355
[TBL] [Abstract][Full Text] [Related]
19. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment.
Zhang S; Huang H; Handley M; Griffin N; Bai X; Shan F
Int Immunopharmacol; 2021 Oct; 99():107999. PubMed ID: 34315116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]